Physician profile
Michael V Elman
NPI 1972770998
$4,022.66
in general payments reported to CMS, 2019-2025
14 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $57.73 · 2021: $2,049 · 2022: $495 · 2023: $492 · 2024: $372 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143 · Education: $59.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.28 |
| Education | $59.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,296.39 | 2021-2023 | Dvr Anatomic Kickstand |
| Stryker Corporation | $1,226.55 | 2021-2025 | Mako, Triathlon |
| Fidia Pharma USA INC. | $603.97 | 2019-2021 | |
| Vericel Corporation | $223.75 | 2022-2025 | Maci |
| Smith+Nephew, INC. | $178.11 | 2022 | |
| Exactech, INC. | $145.80 | 2024 | |
| Pacira Therapeutics, INC. | $97.77 | 2019-2020 | |
| Orthofix Medical, INC. | $70.87 | 2019-2025 | Physio-Stim |
| Bioventus LLC | $58.99 | 2019-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $30.03 | 2024 | Dermabond Prineo, Ethicon, Stratafix |
| Amgen INC. | $25.92 | 2023 | Prolia, Evenity |
| Biocomposites INC | $24.03 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.89 | 2020 | |
| Depuy Synthes Sales INC. | $19.59 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Elman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.